000 | 01290 a2200361 4500 | ||
---|---|---|---|
005 | 20250511150420.0 | ||
264 | 0 | _c19790428 | |
008 | 197904s 0 0 eng d | ||
022 | _a0009-9104 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWalker, S E | |
245 | 0 | 0 |
_aStimulated autoantibody response and increased longevity in NZB/NZW mice treated with cyclophosphamide and tilorone. _h[electronic resource] |
260 |
_bClinical and experimental immunology _cSep 1978 |
||
300 |
_a453-62 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntibody Formation |
650 | 0 | 4 |
_aAutoantibodies _ximmunology |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorenes _xtherapeutic use |
650 | 0 | 4 |
_aGlomerulonephritis _ximmunology |
650 | 0 | 4 |
_aInterferons _xanalysis |
650 | 0 | 4 |
_aLongevity _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred Strains |
650 | 0 | 4 |
_aNeoplasms, Experimental _ximmunology |
650 | 0 | 4 |
_aNeoplasms, Multiple Primary _ximmunology |
650 | 0 | 4 |
_aTilorone _xtherapeutic use |
700 | 1 | _aAnver, M R | |
773 | 0 |
_tClinical and experimental immunology _gvol. 33 _gno. 3 _gp. 453-62 |
|
999 |
_c758241 _d758241 |